Debiopharm Group (Debiopharm) is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. It was founded in 1979 by Rolland-Yves Mauvernay. The group works through its subsidiaries: As of 2010 two drugs had reached the market through its efforts: oxaliplatin for the treatment of cancer, and depot formulations of triptorelin, a gonadotropin-releasing hormone agonist that is used to treat prostate cancer and pedophilia in men, and in women, breast cancer, ovarian cancer, endometriosis, uterine fibromyomas, precocious puberty, and female infertility.

Property Value
dbo:abstract
  • Debiopharm group, généralement appelé simplement Debiopharm, est un groupe pharmaceutique suisse fondé en 1979 et dont le siège se situe à Lausanne, dans l'Immeuble administratif André & Cie S.A. (fr)
  • Debiopharm Group (Debiopharm) is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. It was founded in 1979 by Rolland-Yves Mauvernay. The group works through its subsidiaries: * Debiopharm International SA, which in-licenses product candidates or technologies, develops them, and then licenses them to third parties for commercialization; * Debiopharm Research and Manufacturing SA, which provides contract manufacturing and contract research services to Debiopharm; * Debiopharm Investment SA, which manages the group's money and invests in real estate and in other companies; and * Debiopharm Diagnostics SA, which invests in diagnostics companies. As of 2010 two drugs had reached the market through its efforts: oxaliplatin for the treatment of cancer, and depot formulations of triptorelin, a gonadotropin-releasing hormone agonist that is used to treat prostate cancer and pedophilia in men, and in women, breast cancer, ovarian cancer, endometriosis, uterine fibromyomas, precocious puberty, and female infertility. (en)
dbo:foundationPlace
dbo:foundingYear
  • 1979-01-01 (xsd:date)
dbo:industry
dbo:location
dbo:numberOfEmployees
  • 350 (xsd:integer)
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 21633381 (xsd:integer)
dbo:wikiPageRevisionID
  • 742534308 (xsd:integer)
dbp:areaServed
  • Worldwide
dbp:founder
  • Dr Rolland-Yves Mauvernay
dbp:owner
  • family-owned
dbp:slogan
  • We develop for patients
dct:subject
http://purl.org/linguistics/gold/hypernym
georss:point
  • 46.515 6.641111111111111
rdf:type
rdfs:comment
  • Debiopharm group, généralement appelé simplement Debiopharm, est un groupe pharmaceutique suisse fondé en 1979 et dont le siège se situe à Lausanne, dans l'Immeuble administratif André & Cie S.A. (fr)
  • Debiopharm Group (Debiopharm) is a family-owned biopharmaceutical group of companies headquartered in Lausanne, Switzerland. It was founded in 1979 by Rolland-Yves Mauvernay. The group works through its subsidiaries: As of 2010 two drugs had reached the market through its efforts: oxaliplatin for the treatment of cancer, and depot formulations of triptorelin, a gonadotropin-releasing hormone agonist that is used to treat prostate cancer and pedophilia in men, and in women, breast cancer, ovarian cancer, endometriosis, uterine fibromyomas, precocious puberty, and female infertility. (en)
rdfs:label
  • Debiopharm (fr)
  • Debiopharm (en)
owl:sameAs
geo:geometry
  • POINT(6.6411108970642 46.514999389648)
geo:lat
  • 46.514999 (xsd:float)
geo:long
  • 6.641111 (xsd:float)
prov:wasDerivedFrom
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Debiopharm Group (en)
is dbo:wikiPageRedirects of
is dbp:data of
is foaf:primaryTopic of